Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prehabilitation before hip arthroscopy for femoroacetabular impingement syndrome: A randomised controlled trial.

Clinical rehabilitation·2026
Same author

Glycoursodeoxycholic acid regulates peritoneal monocytic myeloid-derived suppressor cells to alleviate systemic inflammation in decompensated cirrhosis.

Journal of autoimmunity·2026
Same author

Imaging features of porto-sinusoidal vascular disorder in a case-control study: diagnostic value for differentiation from liver cirrhosis.

Quantitative imaging in medicine and surgery·2026
Same author

Polyethylene terephthalate microplastics impair erectile function through macrophage mediated cGAS-STING ferroptosis.

iScience·2026
Same author

Diversity of Gut Microbiota and Metabolites in Benign Prostatic Hyperplasia with Different Prostate Volumes.

European urology open science·2026
Same author

Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapy.

JHEP reports : innovation in hepatology·2025

Related Experiment Video

Updated: Jun 10, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and

Haoyu Wen1,2, Yu Chen1, Qiuxiang Lin3

  • 1Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Ministry of Health, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, China.

Clinical Reviews in Allergy & Immunology
|June 9, 2026
PubMed
Summary

Diagnosing acute-onset autoimmune hepatitis (A-AIH) is challenging, especially when drug exposure is present. A new Dx-AID score effectively differentiates A-AIH from drug-induced autoimmune-like hepatitis (DI-ALH), improving patient care.

Keywords:
Acute-onsetAutoimmune hepatitisDrug-induced autoimmune-like hepatitisDrug-induced liver injury

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

Related Experiment Videos

Last Updated: Jun 10, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

Area of Science:

  • Hepatology
  • Immunology
  • Internal Medicine

Background:

  • Acute-onset autoimmune hepatitis (A-AIH) incidence is rising, posing diagnostic challenges.
  • Distinguishing A-AIH from drug-induced autoimmune-like hepatitis (DI-ALH) is difficult due to similar initial presentations.

Purpose of the Study:

  • To compare A-AIH and DI-ALH in terms of clinical, laboratory, immunological, and histological features.
  • To develop and validate a predictive model for differentiating A-AIH from DI-ALH.

Main Methods:

  • A retrospective, three-center study in China included 238 patients with acute liver injury and autoimmune features.
  • Patients were classified as A-AIH or DI-ALH based on response to drug cessation.
  • A multivariable logistic regression model (Dx-AID score) was developed and validated.

Main Results:

  • A-AIH cases showed higher IgG levels, lower platelets, and higher autoantibody titers than DI-ALH.
  • Histological analysis revealed more severe inflammation and fibrosis in A-AIH.
  • The Dx-AID score demonstrated high diagnostic accuracy (AUC 0.84 in derivation, 0.83 in validation).

Conclusions:

  • A-AIH and DI-ALH exhibit distinct immunological and histological profiles.
  • The Dx-AID score is a practical tool for early differentiation, aiding personalized treatment strategies.